| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 683300.9 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 739639.44 | Peak area | DEHP |
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 881482.25 | Peak area | DEHP |
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 953568.44 | Peak area | Control |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 685404.8 | Peak area | Control |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 720658.56 | Peak area | DEHP |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 794804.4 | Peak area | DEHP |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 855833.06 | Peak area | Control |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|